Outcomes of Culprit‐Only Versus Multi‐Vessel PCI With Impella Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70166 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Raj Patel und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Massachusetts, Worcester, Massachusetts, USA. Hauptthemen laut MEDLINE: Heart-Assist Devices, Shock, Cardiogenic, Percutaneous Coronary Intervention, Myocardial Infarction. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Abdul Moiz Hafiz reports being a consultant for ReCor Medical..
Abstract (Originalsprache)
Background
Current practice for managing acute myocardial infarction complicated by cardiogenic shock (AMI‐CS) involves culprit‐only revascularization with percutaneous coronary intervention (PCI). However, 50% of these patients present with multi‐vessel disease (MVD). In the current era with the availability of more temporary mechanical circulatory support options, the decision to limit PCI to culprit only vessel remains controversial.
Methods
Data from Nationwide Readmission Database between 2016 and 2021 was analyzed for patients over 18 years diagnosed with AMI and CS who underwent PCIs and were supported with percutaneous left ventricular assist device (pLVAD) on day 0. Exclusions included patients receiving coronary artery bypass grafting, heart transplant, durable left ventricular assist devices, extracorporeal membrane oxygenation, intra‐aortic balloon pump, or with chronic total occlusion. Patients were categorized into culprit vessel only PCI (CV‐PCI) and multi‐vessel PCI (MV‐PCI) groups. The primary outcome was in‐hospital mortality. Secondary outcomes included 30‐day mortality, 1 year mortality, 30‐day readmissions, and acute kidney injury (AKI) requiring dialysis.
Results
MV‐PCI group were older patients (67 vs. 65 years, p < 0.001) with significantly higher prevalence of hypertension, type 2 diabetes, peripheral vascular disease, stage 5 chronic kidney disease, and atrial fibrillation. Patients undergoing CV‐PCI had significantly higher rates of ventricular tachycardia/fibrillation and cardiac arrest. No significant differences were found in outcomes between the groups, except for a higher rate of access site hematoma in the MV‐PCI group (1.5% vs. 0.8%, p = 0.02).
Conclusion
In AMI‐CS patients with pLVAD support, MV‐PCI was not associated with increased in‐hospital mortality or AKI requiring dialysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Massachusetts, Worcester, Massachusetts, USA.
- Division of Cardiology, Southern Illinois University School of Medicine, Springfield, Illinois, USA.
- Department of Internal Medicine, Southern Illinois University School of Medicine, Springfield, Illinois, USA.
- Midwest Cardiovascular Institute, Naperville, Illinois, USA.
- Department of Internal Medicine, Nassau University Medical Centre, East Meadow, New York, USA.
Förderung
- Abdul Moiz Hafiz reports being a consultant for ReCor Medical.
Zitieren
APA
Patel, R., Ghanem, F., Rafique, S., DeMartini, T., Turk, A. A., Patel, A., & Hafiz, A. M. (2025). Outcomes of Culprit‐Only Versus Multi‐Vessel PCI With Impella Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70166
Vancouver
Patel R, Ghanem F, Rafique S, DeMartini T, Turk AA, Patel A, et al. Outcomes of Culprit‐Only Versus Multi‐Vessel PCI With Impella Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70166
BibTeX
@article{Patel2025,
author = {Patel, Raj and Ghanem, Fares and Rafique, Soomal and DeMartini, Tony and Turk, Ahmad Al and Patel, Apurva and Hafiz, Abdul Moiz},
title = {Outcomes of Culprit‐Only Versus Multi‐Vessel PCI With Impella Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70166}
}
EUVIMED